Objective-The myogenic response is central to blood flow regulation in the brain. Its induction is tied to elevated cytosolic [Ca 2+ ], a response primarily driven by voltage-gated Ca 2+ channels and secondarily by Ca 2+ wave production. Although the signaling events leading to the former are well studied, those driving Ca 2+ waves remain uncertain. Approach and Results-We postulated that α v β 3 integrin signaling is integral to the generation of pressure-induced Ca 2+ waves and cerebral arterial tone. This hypothesis was tested in rat cerebral arteries using the synergistic strengths of pressure myography, rapid Ca 2+ imaging, and Western blot analysis. GRGDSP, a peptide that preferentially blocks α v β 3 integrin, attenuated myogenic tone, indicating the modest role for sarcoplasmic reticulum Ca 2+ release in myogenic tone generation. The RGD peptide was subsequently shown to impair Ca 2+ wave generation and myosin light chain 20 (MLC 20 ) phosphorylation, the latter of which was attributed to the modulation of MLC kinase and MLC phosphatase via MYPT1-T855 phosphorylation. Subsequent experiments revealed that elevated pressure enhanced phospholipase Cγ1 phosphorylation in an RGD-dependent manner and that phospholipase C inhibition attenuated Ca 2+ wave generation. Direct inhibition of inositol 1, 4, 5-triphosphate receptors also impaired Ca 2+ wave generation, myogenic tone, and MLC 20 phosphorylation, partly through the T-855 phosphorylation site of MYPT1. Conclusions-Our investigation reveals a hitherto unknown role for α v β 3 integrin as a cerebral arterial pressure sensor.
T he cardiovascular system is composed of a muscular pump and a distribution network of arteries, veins, and capillaries, which attend to tissue metabolic demands. Within this integrated system, resistance arteries control the magnitude and distribution of tissue blood flow by responding to neurotransmitters, metabolites, and mechanical forces, such as intravascular pressure. [1] [2] [3] The myogenic response refers to an artery's ability to constrict to elevated pressure, a response of particular prominence in the brain. 4, 5 Past studies have shown that the myogenic response is transduced by changes in myosin light chain kinase (MLCK) and phosphatase (MLCP) activity, along with cytoskeletal organization. 6 These downstream events are intimately, although not exclusively, linked to global [Ca 2+ ], an event primarily controlled by voltage-gated Ca 2+ channels. [7] [8] [9] Although extracellular Ca 2+ influx is of key importance, recent work has revealed that pressure also mobilizes Ca 2+ from the sarcoplasmic reticulum (SR) to modestly facilitate tone development. [10] [11] [12] Smooth muscle Ca 2+ waves are slow asynchronous events, which spread from end-to-end in a voltage insensitive manner. 10, 13 This internal release of Ca 2+ from SR induces myosin light chain 20 (MLC 20 ) phosphorylation by: (1) activating MLCK and (2) inhibiting MLCP via phosphorylation of MYPT1-T855. 9 Although Ca 2+ waves have been linked to myogenic tone particular at pressures where vessels are more hyperpolarized, 10 the signaling mechanisms driving these transient events, are yet to be fully elucidated.
Integrin receptors are membrane-bound glycoproteins that link the extracellular matrix to the actin cytoskeleton. Given their cellular positioning, they are often viewed as presumptive mechanotransducers; an interpretation consistent with integrin blockade (ie, α V β 3 , α 4 β 1 ) impairing pressure-induced constriction in skeletal muscle resistance arteries. 14 As key members of focal adhesion complexes, integrins play an essential role in regulating other structural and signaling proteins. This includes focal adhesion kinase, an enzyme which when active, forms a high-affinity binding site with phospholipase Cγ1 (PLCγ1) inducing its phosphorylation. [15] [16] [17] [18] [19] Activation of PLCγ1 could facilitate inositol 1,3,4 triphosphate (IP 3 ) December 2015 production and drive Ca 2+ wave generation by opening its like named receptor (IP 3 R). 18, 20, 21 In this study of the cerebral circulation, we investigated whether the α V β 3 integrin facilitates Ca 2+ wave generation and myogenic tone through a signaling cascade, involving PLCγ1 and IP 3 R. To test this hypothesis, we used a methodological approach that synergistically combined pressure myography, rapid Ca 2+ imaging, and Western blot analysis. We found that inhibiting α V β 3 integrin partially impaired myogenic tone, demonstrating the modest role of SR Ca 2+ waves in the generation of myogenic tone. Consistent with the functional observations, elevated pressure was also shown to increase Ca 2+ wave generation in rat cerebral arteries. These pressureinduced Ca 2+ events were attenuated by α V β 3 -blocking peptides and facilitated MLC 20 phosphorylation by augmenting MLCK activity and inhibiting MLCP via the phosphorylation of MYPT1-T855. Further experiments revealed that: (1) elevated pressure augmented PLCγ1 phosphorylation in a α V β 3dependent manner and (2) inhibiting PLC or IP 3 Rs diminished myogenic tone, Ca 2+ wave production, and MLC 20 phosphorylation. Cumulatively, this investigation demonstrates that α v β 3 integrin functions as a mechanosensor, facilitating Ca 2+ wave generation through a signaling cascade, involving PLCγ1 and IP 3 R activation. Ca 2+ waves, in turn, enable MLC 20 phosphorylation and, in part, myogenic tone by regulating MLCK and MLCP activity.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Blocking α v β 3 Integrin Attenuates Myogenic Tone
Experiments began by isolating cerebral arteries and using quantitative polymerase chain reaction to assess integrin mRNA expression. This analysis revealed the presence of 5α and 4β integrins, including those comprising α v β 3 and α 4 β 1 ( Figure IA and IB in the online-only Data Supplement). Next, endothelial intact arteries were cannulated and rapidly pressurized from 15 to 80 mm Hg; diameter was subsequently assessed under control conditions and after treatment with peptides that preferentially block the α v β 3 integrin. The GRGDSP peptide attenuated myogenic tone in a concentration-dependent manner, whereas its inactive analog GRADSP had no effect ( Figure IC and ID in the onlineonly Data Supplement). Given that the myogenic response is intrinsic to smooth muscle and that endothelial integrins may introduce a confounding influence, proceeding experiments were repeated in endothelial denuded arteries. Figure IE and IF in the online-only Data Supplement shows that GRGDSP peptide attenuated myogenic tone in a concentration-dependent manner. The inactive analog GRADSP had no effect except at the highest concentration (210 μmol/L) where a notable constriction was observed. Antagonizing β 3 integrin with a monoclonal antibody also attenuated pressure-induced responses (diameter at 15 mm Hg-diameter at 80 mm Hg) in cerebral arteries (control, −23.1±3.5 versus antibody treated, 11.99±2.54; P<0.05; n=5). Further control experiments implicated a role for the α 4 β 1 integrin in the myogenic response as the EILDVSPT-blocking peptide diminished vasomotor tone ( Figure II in the online-only Data Supplement). The inactive peptide analog had no significant effect, barring the highest concentration tested (210 μmol/L).
Blocking α v β 3 Integrin Attenuates Ca 2+ Waves and MLC 20 Phosphorylation
Having ascertained that a 70-μmol/L concentration of α v β 3 integrin-blocking peptide moderates the myogenic response, we next sought to investigate its effects on Ca 2+ signaling. As above, arteries were rapidly pressurized to 80 mm Hg and after 5 minutes, diameter was assessed under control conditions and after treatment with RGD/RAD peptide+diltiazem (30 μmol/L, L-type Ca 2+ channel blocker) or ryanodine (10 μmol/L; SR depletion agent). Cerebral arteries treated with α v β 3 -blocking peptide (RGD) displayed attenuated myogenic tone ( Figure 1A and 1B), whereas the inactive analog (RAD) had no effect ( Figure 1C and 1D). Incubating RGD/RADtreated vessels with diltiazem, further attenuated myogenic tone confirming that L-type Ca 2+ channels remained active after α v β 3 integrin blockade. In contrast, ryanodine did not attenuate myogenic tone in arteries pretreated with RGD peptide; it did, however, modestly attenuate tone in RAD-treated vessels ( Figure 1E -1H). The latter observation aligns with previous myogenic experiments using ryanodine. 10 Together, these observations indirectly suggest that α v β 3 integrins contribute to SR store mobilization and Ca 2+ wave generation, independent of L-type Ca 2+ channel activity. The preceding analysis assumes that RGD peptides have few nonmyogenic effects.
Given the preceding novel but suggestive observations, we next used rapid Ca 2+ imaging to directly examine whether α v β 3 integrin was involved in the generation of pressure-induced Ca 2+ waves. Cerebral arteries were loaded with Fluo-4 AM and Ca 2+ waves monitored in the absence and presence of the α v β 3 integrin-blocking peptide (RGD) or its inactive analog (RAD). Pressurization to 80 mm Hg increased the frequency and percentage of cells firing Ca 2+ waves ( Figure 2) ; past work has noted that these events are voltage insensitive and unaffected by diltiazem, an L-type Ca 2+ channel blocker. 10 Pressure-induced Ca 2+ waves were markedly attenuated by the RGD but not by the RAD peptide. In a complimentary manner, the RGD but not RAD peptide diminished the ability of intravascular pressure to induce MLC 20 phosphorylation ( Figure 3A ). Exposing RGD-treated arteries to diltiazem further reduced pressure-induced MLC 20 phosphorylation, whereas ryanodine application had no effect. The latter observation is consistent with α v β 3 integrin signaling directing the phosphorylation of this key contractile protein through Ca 2+ wave generation. The ability of α v β 3 integrin and Ca 2+ waves to enhance MLC 20 phosphorylation could arise, in part, to MLCP inhibition, as mediated through MYPT1-T855 phosphorylation ( Figure III in the online-only Data Supplement). 10 Consistent with this perspective, we observed that cerebral arteries treated with RGD but not RAD peptide reduced the ability of pressure to induce MYPT1-T855 phosphorylation ( Figure 3B ). In addition, we found that MYPT1-T855 phosphorylation in RGD-treated arteries was reduced by the further application of diltiazem but not ryanodine. The preceding perturbations did not influence MYPT1 T-697 phosphorylation ( Figure 3C ), a second regulatory site on this targeting subunit.
Blocking α v β 3 Integrin Impairs Downstream PLCγ1 Signaling
Integrin receptors can recruit and activate PLCγ1. 19, 22 Consistent with α v β 3 integrin mobilizing this phospholipase, elevated pressure augmented PLCγ1-Y783 phosphorylation, an effect attenuated by RGD but not RAD peptide ( Figure 4A ). The general PLC inhibitor U73122 was subsequently shown to diminish Ca 2+ waves, whereas the inactive analog (U73433) was without effect ( Figure 4B and 4C). PLC inhibition by U73122 also markedly reduced MLC 20 phosphorylation and myogenic tone development ( Figure IV in the online-only Data Supplement), whereas its inactive analog (U73433) did not influence these parameters. Phosphorylation of PLCγ1 will result in diacylglycerol and IP 3 production, the latter of which triggers Ca 2+ waves via IP 3 Rs. Three sequential data sets connect these elements, the first being that IP 3 R inhibitors (xestospongin C or 2-APB) decreased the frequency and number of cells firing Ca 2+ waves in arteries pressurized to 80 mm Hg ( Figure 5A-5D ). Next, bath application of xestospongin C and 2-APB ( Figure 5E -5H) decreased that component of the myogenic response insensitive to diltiazem, an L-type Ca 2+ channel inhibitor. Finally, this study showed that while pressure-induced increases in MLC 20 phosphorylation were moderated by diltiazem, further attenuation was induced by adding xestospongin C on top of this L-type Ca 2+ channel blocker ( Figure 6A ). Xestospongin C's ability to reduce MLC 20 phosphorylation can be ascribed, in part, to MLCP inhibition, as this IP 3 R inhibitor reduced MYPT1-T855 phosphorylation in diltiazem-treated arteries ( Figure 6B ). MYPT1-T697 phosphorylation was unaffected, neither by changes in intravascular pressure nor by the addition of diltiazem or xestospongin C ( Figure 6C ).
Discussion
A century ago, Bayliss described the intrinsic ability of arteries to respond to intravascular pressure. 4 The myogenic response is prominent in the cerebral circulation and is enabled by a global rise in cytosolic [Ca 2+ ] that drives MLC 20 phosphorylation and also actin polymerization. 3, 10 Although pressure-induced increases in cytosolic [Ca 2+ ] are principally dependent on membrane depolarization and L-type Ca 2+ channel activation, recent studies have noted a modest role for SR Ca 2+ release. 3, [8] [9] [10] 23 Ca 2+ waves are asynchronous, voltageinsensitive events that propagate from end-to-end, enhancing MLC 20 phosphorylation through MLCK activation and by inhibiting MLCP via MYPT1-T855 phosphorylation. 9, 24 Its relative importance is more evident at lower pressures where vessels are hyperpolarized and L-type Ca 2+ channel activity is limited by their voltage-dependent properties. At present, it is unknown how cerebral arteries sense intravascular pressure so as to induce these repetitive Ca 2+ events. One potential mechanism could entail the mobilization of integrin receptors, membrane-spanning glycoproteins connecting the extracellular matrix to the cytoskeleton. 6, 13 Nine distinct integrin receptor subunits are expressed in cerebral arteries ( Figure IA and IB in the online-only Data Supplement) and past studies using skeletal muscle arteries have shown that α V β 3 , along with α 4 β 1 and α 5 β 1 , are key players in pressure-induced responses. 14, [25] [26] [27] Integrin receptors are part of focal adhesion complexes, which when stimulated, recruit a full complement of signaling proteins. 19, 22 The recruited proteins include PLCγ1, a phospholipase that could in theory initiate Ca 2+ waves by generating IP 3 and stimulating IP 3 Rs. 18, 28, 29 In keeping with this historical narrative, we began to explore the linkage between luminal pressure, integrin signaling, Ca 2+ wave generation, and myogenic tone in cerebral arteries. We focused on α V β 3 integrin considering (1) mRNA expression in cerebral arteries, (2) the availability of specific pharmacological tools, and (3) its ability to influence myogenic tone independent of voltage and L-type Ca 2+ channel activity, as in the case of α 4 β 1 and α 5 β 1 . 16,30-32 A functional assay was initially developed where cerebral arteries were rapidly pressurized (15-80 mm Hg) and tone assessed during and after a 5-minute test period; this protocol was repeated in the absence and presence of an increasing concentration of RGD or RAD peptides. Analogous to skeletal muscle resistance arteries, we observed that the RGD peptide, which preferentially targets α v β 3 integrin, elicited a concentration-dependent dilation. 14 The control RAD peptide was without effect except at the highest concentration where a constriction was observed ( Figure I in the online-only Data Supplement). Having established a working peptide concentration of 70 μmol/L, we next addressed whether α v β 3 integrin blockade attenuated myogenic tone by altering L-type Ca 2+ channel activity or SR Ca 2+ wave generation. In this regard, cerebral arteries were pretreated with the peptide and tone was assessed before or after blockade of L-type Ca 2+ channels or Ca 2+ wave generation. It was rationalized that if RGD-treated arteries failed to dilate either to diltiazem or to ryanodine, then α v β 3 integrin blockade was impairing that particular aspect of Ca 2+ regulation. Control experiments revealed that RAD-treated arteries developed less myogenic tone after the addition of diltiazem or ryanodine (Figure 1) . In contrast, ryanodine's ability to attenuate myogenic tone was selectively lost in RGD-treated arteries, consistent with α v β 3 integrins triggering SR Ca 2+ waves. This result was verified by loading cerebral arteries with Fluo-4 AM and pressurizing vessels to 80 mm Hg, inducing production of Ca 2+ waves. These asynchronous events (frequency, ≈0.2 Hz) were evident in ≈80% of smooth muscle cells and blocking α v β 3 induced a notable reduction in Ca 2+ waves; the control RAD peptide was without effect. Together, these observations indicate that α v β 3 integrin and its associated signaling pathway play a primary role in the triggering of Ca 2+ waves. This analysis assumes that RGD peptides have few nonmyogenic effects.
Mufti et al 10 previously showed that Ca 2+ waves augment myogenic tone by providing a proportion of the Ca 2+ required to enhance MLC 20 phosphorylation. Consequently, it followed that this key parameter should be measured before and after α v β 3 inhibition. Findings in Figure 3 showed that RGD but not the control RAD peptide lowered MLC 20 phosphorylation in pressurized cerebral arteries. It also showed that in RGDtreated arteries, the subsequent application of diltiazem but not ryanodine (an SR-depleting agent) further reduced MLC 20 phosphorylation. This finding is consistent with α v β 3 integrin driving this key phosphorylation step through Ca 2+ wave suppression rather than through substantive changes in L-type Ca 2+ channel activity. In theory, Ca 2+ waves could facilitate MLC 20 phosphorylation by (1) binding to calmodulin and relieving auto inhibition of MLCK 24 or (2) inhibiting MLCP through a Rho kinase-linked pathway previously shown to promote MYPT1-T855 phosphorylation (control data reprinted in Figure III in the online-only Data Supplement). 10 In regard to the latter observation, we confirmed that the α v β 3blocking peptide RGD impaired pressure-induced phosphorylation of MYPT1-T855. We also showed that in RGD-treated arteries, diltiazem but not ryanodine attenuated MYPT1-T855 phosphorylation, consistent with α v β 3 integrin-linked Ca 2+ waves modulating the targeting subunit of MLCP. Unlike the T855 site, MYPT1-T697 phosphorylation was unaffected by peptide treatment or the application of L-type Ca 2+ channel blockers or Ca 2+ wave inhibitors.
The inherent ability of α v β 3 to target myogenic mechanisms largely independent of L-type Ca 2+ channels suggests . Effects of α V β 3 integrin or phospholipase C (PLC) inhibition on PLCγ1 phosphorylation and Ca 2+ wave generation. A, Paired cerebral arteries were pressurized from 20 to 80 mm Hg for 5 minutes before and after treatment with α V β 3 control (RAD, 70 μmol/L) or blocking (RGD, 70 μmol/L) peptide. Vessels were subsequently frozen in acetone and processed for phosphorylation assessment of PLCγ1-Y783 (n=5 arterial pairs from 5 animals). B-E, Cerebral arteries were loaded with Fluo-4, cannulated and pressurized to 80 mm Hg. Ca 2+ waves were monitored before and after treatment with the PLC inhibitor U73122 (500 nmol/L) or its inactive analog U73343 (500 nmol/L). Representative illustrations and summary data (n=5 arteries from 5 animals, 50 cells in total) are presented in B and C and D and E, respectively. *Significant increase from the preceding experimental step. that >1 integrin is involved in smooth muscle mechanotransduction. This perspective is consistent with Figure II in the online-only Data Supplement, which highlights the ability of α 4 β 1 peptide blockers to moderate pressure-induced constriction. Similarly, Martinez-Lemus et al 14 have shown in skeletal muscle arteries that peptide/antibody inhibitors of α v β 3 and α 4 β 1 both negatively affected myogenic tone. Recent work has also implied a role for α 5 β 1 in the regulation of L-type Ca 2+ channel and other ionic conductances involved in the control of arterial V M . 16, 30, 31 Such effects seem to be mediated through signaling pathways linked to the SRC (sarcoma) family of tyrosine kinases. 30, 32 Cell culture work focused on integrin signaling has noted that these receptors can mobilize focal adhesion kinase. 33 Through a high-affinity binding site, this kinase can phosphorylate PLCγ1 at Y783, a response that results in activation and induction of IP 3 production. 19 Two key sets of experiments link PLC, in particular PLCγ1, to α v β 3 integrins and the induction of pressure-induced Ca 2+ waves. First, biochemical measures conducted on paired cerebral arteries revealed that intravascular pressure enhanced PLCγ1-Y783 phosphorylation, a response diminished by RGD but not by the control RAD peptide ( Figure 4A ). Second, we found that the percentage of cells firing Ca 2+ waves along with event frequency decreased in arteries treated with U73122, a broad-spectrum PLC inhibitor ( Figure 4B-4E) . Similar changes were absent in vessels treated with the inactive analogue U73343. Although Figure III in the online-only Data Supplement shows that U73122 markedly attenuated MLC 20 phosphorylation and myogenic tone, it is important to recognize that these robust effects cannot be singularly attributed to IP 3 production and the loss of Ca 2+ waves. Diacylglycerol generation will be equally impaired by PLC inhibition and this effect will, in turn, affect TRP (transient receptor potential) channel activation, arterial depolarization, and Ca 2+ influx via the voltage-gated Ca 2+ channels. 34, 35 Given the preceding findings, we hypothesized that IP 3 Rs are essential to the triggering of Ca 2+ waves, MLC 20 phosphorylation and consequently myogenic tone in the cerebral circulation. Three sets of experiments strengthen this linkage, the first centered on Ca 2+ waves and the inherent ability of IP 3 R inhibitors (xestospongin C or 2-APB) to reduce the frequency and number of cells firing these events in cerebral arteries ( Figure 5A-5D ). The second involved assessing myogenic tone over a full pressure range and showing that the same inhibitors attenuated the residual component of the myogenic response insensitive to L-type Ca 2+ channel blockade ( Figure 5E-5H ). Finally, Western blot analysis confirmed that in diltiazem-treated arteries, IP 3 R inhibition further reduced residual MLC 20 phosphorylation ( Figure 6A ). This finding is consistent with Ca 2+ waves moderating MLCK activation and secondarily MLCP inhibition through the MYPT1 T-855 phosphorylation site ( Figure 6B and 6C) .
The preceding findings highlight for the first time the importance of α v β 3 signaling in activating IP3R 3 to facilitate Ca 2+ wave generation, MLC 20 /MYPT1 phosphorylation, and in part myogenic tone development. This work compliments the findings by Westcott et al, 36 who previously implicated the involvement of PLC and IP 3 R in pressure-induced Ca 2+ waves. The presence of pressure-induced Ca 2+ waves raises an important question centered on why these transient events, along with extracellular Ca 2+ influx are both required to maintain the myogenic response. We argue that because Ca 2+ wave generation is voltage independent, 10 these events will be present for a broad range of physiological conditions. As such, a degree of Ca 2+ signaling will always be present in a cerebral artery to aid with tone development.
Summary
Myogenic tone is driven by changes in cytosolic [Ca 2+ ], an event intimately tied to L-type Ca 2+ channel activity and secondarily to Ca 2+ wave generation. 3, 10 Focusing on Ca 2+ waves, this study elucidated an unknown role for α v β 3 integrins and downstream PLCγ1 signaling in the induction of pressuresensitive events. It further showed that Ca 2+ waves enhanced myogenic tone by providing a proportion of the Ca 2+ needed to drive MLC 20 phosphorylation. By elucidating the mechanosensory component of myogenic tone in the cerebral circulation, this study advances the foundational knowledge in Ca 2+ dynamics, vascular tone development, and ultimately the regulation of brain blood flow.
